Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Fatigue in Adolescent Long COVID
NCT06147050Phase 3Not yet recruiting
- Sponsor
- Purpose Life Sciences
- Start
- Apr 2024
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metformin in post-acute sequelae of SARS-CoV-2 infection (PASC), myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS), sponsored by Purpose Life Sciences. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
metformin
03
Conditions
post-acute sequelae of SARS-CoV-2 infection (PASC)myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS)
Beyond the preview
Go deeper on NCT06147050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06147050.